Articles

Recent articles

  1. Study protocol

    Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and poor prognosis due to red blood cell transfusion–dependent anemia and thrombocytopenia

    Guillermo Garcia-Manero, Antonio Almeida, Aristoteles Giagounidis, Uwe Platzbecker, Regina Garcia, Maria Teresa Voso, Stephen R. Larsen, David Valcarcel, Lewis R. Silverman, Barry Skikne and Valeria Santini

    Published on: 3 May 2016

  2. Research article

    Characteristics of chronic lymphocytic leukemia in Senegal

    Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour, Seynabou Fall, Abdoulaye Sène, Blaise Félix Faye, Moussa Seck, Macoura Gadji, Tandakha Ndiaye Dièye, Claire Mathiot, Sophie Reynaud, Saliou Diop and Martine Raphaël

    Published on: 23 April 2016

View all articles

Most accessed articles

View all articles

Aims and scope

BMC Hematology is an open access, peer-reviewed journal that considers articles on basic, experimental and clinical research related to hematology. The journal welcomes submissions on non-malignant and malignant hematological diseases, hemostasis and thrombosis, hematopoiesis, stem cells and transplantation.

Section Editor

  • Mary J Laughlin, Division of Hematology/Oncology, University of Virginia
  • Alejandro Lazo-Langner, University of Western Ontario

Executive Editor

  • Nawsheen Boodhun, BioMed Central

Tweets

Advertisement